Michael finds a way to see ‘beautiful things’ again
CBR Business News, 24 May, 2022
Royal Australian Air Force officer of 16 years, Michael Raymond, speaks about psychedelic-assisted therapies.
Insight Ep 13: Illicit Medicine
SBS, 09 May, 2022
Is the war on drugs holding us back from developing new therapies, and denying people viable treatments?
Biotechs want to unlock the psychedelics market, but it isn’t simple
The Sydney Morning Herald, 08 May, 2022
Australian biotechs are high on optimism about the multi-billion dollar potential of psychedelic treatments for mental health, but regulators still have question marks.
The Year that Made Me: Tania De Jong, 2017
ABC Sunday Extra, 24 April, 2022
MMA’s Executive Director, Tania de Jong AM, talks about undergoing psychedelic therapy and the focus it gave her. She is currently in rehearsal for the premiere season of the musical, Driftwood, which is based on the memoir of her mother, Eva, and the story of her grandparents, who escaped the Holocaust.
Could psychedelic mushrooms be the answer to treating depression?
6PR Mornings with Liam Bartlett, 13 April, 2022
Listen to our Executive Director, Tania de Jong AM, discuss the potential in psychedelic medicines on 6PR Mornings with Liam Bartlett.
PharmAla Biotech to supply Mind Medicine Australia with GMP MDMA for Clinical Trial
News Wire, 08 April, 2022
PharmAla’s GMP MDMA will accelerate trial work funded by Australia’s premier Psychedelics charity.
Professor David Nutt (UK) Interview on FM104
FM104, 05 April, 2022
Mind Medicine Australia Ambassador Professor David Nutt (UK) discusses the current state of psychedelics including the progress with Mind Medicine Australia.
Can microdosing psychedelics help curb anxiety?
Healthy-ish Podcast, 04 April, 2022
Executive Director of Mind Medicine Australia, Tania de Jong AM, discusses the potential in psychedelic-assisted psychotherapies.
Could MDMA be the answer for sick Aussies?
I've Got News For You (News.com.au), 24 March, 2022
There’s a push to change the law to allow patients with treatment-resistant mental illnesses to access MDMA-assisted therapies. Bucky investigates how it would work.
The case for magic mushrooms as mental health treatment
The Briefing Podcast, 23 March, 2022
Psychiatrist and Director of Mind Medicine Australia, Dr Eli Kotler, was recently a guest on The Briefing Podcast. In the episode he discusses the progress we have had, and our current application of rescheduling MDMA and psilocybin with the TGA.
Could psychedelic drugs be the breakthrough treatment for mental health issues?
Studio10, 25 February, 2022
Could psychedelic drugs be the breakthrough treatment for mental health issues? Michael Raymond’s 16-year-career in our airforce left him battling PTSD, anxiety, and depression, but found to be the cure he needed.
What’s Next for Australia’s Psychedelics Movement?
Truffle Report, 17 February, 2022
Truffle Report reached out to MMA’s co-founder and chair Peter Hunt for an update on the charity’s efforts to legalize psilocybin and MDMA as medicines for patients in Australia.
Drug of choice: support is growing for greater use of psychedelic-assisted therapy
The Daily Telegraph, 16 February, 2022
Scott Leckie and Tania de Jong AM discuss the growing support for the use of psychedelic-assisted therapy.
State roadblocks TGA approval of psychedelic-assisted therapies
6PR Mornings, 10 February, 2022
Former Chief of Australia’s Defence Force and Mind Medicine Australia board director Professor Admiral (Ret) Chris Barrie AC said Australia’s TGA has given 40 approvals to doctors to provide certain treatments to patients suffering from treatment-resistant PTSD on a case by case basis.
Turn on, tune in, get well?
The Australian, 29 January, 2022
Psychedelic therapy is back on the agenda. And for the likes of Andrew Robb, it’s high time.
How Psychedelic Medicines Changed Tania de Jong’s Life
The Carousel, 24 January, 2022
Tania de Jong, Executive Director at Mind Medicine Australia, shares how psychedelic medicine has changed her life.
Mind Medicine with Tania de Jong & Charles Kovess
TNT Radio, 24 January, 2022
Join Tania de Jong AM and Charles Kovess in exploring solutions to the Mental Health crisis. Every 2nd Saturday.
Quest for new mental illness treatments continues with MDMA and psilocybin trial
Examiner, 18 January, 2022
New research looking into the effects of MDMA and psilocybin on the brain is set to take place as part of a continuing push to make psychedelic medicines a mainstream treatment for depression and other mental health disorders
'This is not palliative care; this is curative': How MDMA could be used to treat depression and PTSD
ABC Mornings, 18 January, 2022
Mind Medicine Australia chairman Peter Hunt says clinical trials in the use of psychedelic medicines could be “curative” for people living with mental illnesses.
The Power of Psychedelic Assisted Therapies
Crappy to Happy Podcast, 14 January, 2022
In this episode of the Crappy to Happy podcast, host Cass Dunn chats with Tania de Jong AM, who is a social entrepreneur, incredibly talented soprano and co-founder of the not-for-profit, Mind Medicine Australia.
Mind Medicine Australia joins global coalition launched to secure a rescheduling of psilocybin under the 1971 UN Convention on Psychotropic Substances
Mind Medicine Australia, 13 January, 2022
Today Mind Medicine Australia joins in the launch of the International Therapeutic Psilocybin Rescheduling Initiative (ITPRI), a global coalition working to promote and secure a rescheduling of psilocybin under the 1971 Convention on Psychotropic Substances
Announcing a Major Healthy Persons Trial to Investigate the Brain Activity Effects of Psychedelic Medicines
Mind Medicine Australia, 10 January, 2022
Mind Medicine Australia (MMA) is delighted to announce that it is part-funding a clinical trial which has just received Human Research Ethics approval and is designed to study the brain activity of participants after taking psychedelic medicines.
Find Your Voice: How This Acclaimed Australian Soprano Believes That Together We Can Change The World One Voice At A Time
Finding Genius Podcast, 24 December, 2021
Our Executive Director Tania de Jong AM was interviewed in this podcast about her work with mental health charities Creativity Australia and Mind Medicine Australia.
From Investment Banking To Psychedelics: Changing The Treatment Paradigm For Mental Illness With Peter Hunt
Wake the f*** up podcast, 21 December, 2021
This podcast is an exploration into Peter Hunt’s journey into spirituality and finding greater connection, meaning and peace which led to the establishment of Mind Medicine Australia with his wife Tania de Jong. It also explains why it is so urgent for psychedelic-assisted therapies to become part of our mental health system and the importance of Governments becoming proactive in this field, rather than reactive. There is so much suffering which could be alleviated through these transformational therapies.
Emyria to expand Real World Data assets for MDMA-assisted therapy trials by incorporating wearables monitoring
Emyria (ASX: EMD ) Press Release, 20 December, 2021
Emyria’s phase 2b MDMA-assisted therapy trial for severe Post Traumatic Stress Disorder (PTSD), EMDMA-001, developed with registered charity Mind Medicine Australia (MMA), will be the first program to incorporate Cydelic technology and is expected to be one of the first programs in the world to incorporate remote patient monitoring within MDMA-assisted therapy.
TGA blocks use of MDMA, magic mushrooms trials for mental health
AFR, 17 December, 2021
Australia’s medicines regulator has rejected a call to legalise psychedelic drugs for use in mental health settings.
The Wellness Couch Podcast, Episode #92 with Tania de Jong AM
The Wellness Couch Podcast, 16 December, 2021
In this podcast, Mind Medicine Australia Executive Director, Tania de Jong AM, shares more about psychedelic-assisted psychotherapies and their potential for healing mental illness.
TGA blocks bid to have MDMA, magic mushrooms used to treat mental health conditions
ABC News, 16 December, 2021
Australia’s medicines regulator has rejected a call to legalise psychedelic drugs for use in mental health settings.
TGA says NO again to psychedelic-assisted therapies
Mind Medicine Australia, 15 December, 2021
Mind Medicine Australia’s Response to the Announcement of the TGA NOT to Reschedule the Medical Use of MDMA for Treatment Resistant PTSD and the Medical Use of Psilocybin for Treatment Resistant Depression as Part of Therapy.
Return trip: Psychedelics have made a comeback in the treatment of mental illness
Wellspring Mag, 01 December, 2021
In this interview, Tania de Jong AM, Executive Director at Mind Medicine Australia, discusses the re-emergence of psychedelic-assisted therapy.
MDMA and psilocybin could be removed from the TGA's list of prohibited medicines
ABC RN Breakfast, 03 December, 2021
In this interview MMA Ambassador, Prof David Nutt (UK), speaks about Australia’s drug regulator, the Therapeutic Goods Administration, who is soon set to announce if psilocybin and MDMA should be removed from the prohibited medicines list: “I have to say, one of the things I have been doing a lot here is teaching on Mind Medicine Australia training course which I think is the best course in the world on educating people about how to use psychedelics and how to develop.” (6:19 onwards)
A former defence force chief has joined a push to treat post traumatic stress disorder with MDMA
9News, 18 November, 2021
Admiral Chris Barrie AC, a former Defence Force Chief from our board and Veteran Michael Raymond were recently interviewed on 9News. We are advocating for psychedelic medicines which can offer hope to those suffering from severe PTSD and depression.
TGA considering change to classification of psychedelics
ABC News, 17 November, 2021
Psychiatrist Dr Stuart Saker says there’s compelling evidence that some psychedelic drugs make effective treatments for people with post-traumatic stress disorder or depression.
Momentum for psychedelic-assisted therapies building in New Zealand
Newshub.co.nz, 30 October, 2021
“Sometimes the government has a chance to do something fantastic. And something revolutionary, and this would be one of those times.”
Clinical use of psilocybin
9News Gold Coast, 22 October, 2021
The clinical use of psilocybin and MDMA to treat mental illness could soon be available to every Australian. A former Rugby player and Gold Cost local now throwing his support behind the approach.
TGA review psychedelics for mental health treatment
ABC, RN Breakfast, 07 October, 2021
Andrew Robb AO, MMA Board Member and previously the Australian Government Minister for Trade, speaks on Radio National about the urgent need to reschedule the medical use of MDMA and Psilocybin as part of therapy for the treatment of depression and PTSD.
Tasmanian mental health patients "holding out hope" for MDMA and magic mushrooms treatments
The Advocate, 01 October, 2021
The legal use of MDMA and psilocybin as treatments for mental health conditions such as anxiety and post-traumatic stress disorder could potentially be one step closer, with the national drugs regulator finding they have therapeutic benefits.
Magic Mushrooms and MDMA could be approved for mental health conditions by TGA
Herald Sun, 01 October, 2021
MDMA and Psilocybin have moved a step closer to being approved for use in mental health in Australia.
Brave New Psychedelic World
Australia Women's Weekly, 13 September, 2021
As the world’s mental health crisis worsens psilocybin and MDMA are emerging as promising new treatments.
‘Psychedelics renaissance’: new wave of research puts hallucinogenics forward to treat mental health
The Guardian, 26 September, 2021
In what’s been described as a ‘paradigm shifter’ for psychiatry, Australian clinical trials are exploring the therapeutic benefits of illegal substances.
How Mind Medicine Australia Is Tackling Deadly Mental Health Crisis with Psychedelics
Psychedelic Spotlight, 16 September, 2021
Charity co-founder Tania de Jong says Covid-19 pandemic has led to “a huge spike in mental health issues including, very sadly, suicides,” and she believes psychedelics are a solution.
Legalising Illicit Therapies: Why Psychedelics Could Be The Most Important Mental Health Breakthrough Of The 21st Century
Refinery29, 17 September, 2021
Why Psychedelics Could Be The Most Important Mental Health Breakthrough Of The 21st Century.
Magic Mushrooms // The Medicine That Can Change Your Life
Carnage House Productions, 16 September, 2021
This interview with Tania de Jong AM, focuses on the benefits of psilocybin and MDMA assisted therapies for sufferers of depression, anxiety, PTSD and alcohol/nicotine addiction.
Mind Medicine Australia to host Australia’s Inaugural International Summit on Psychedelic Therapies for Mental Illness online in November 2021
Mind Medicine Australia, 02 September, 2021
Mental health charity Mind Medicine Australia (MMA) is delighted to announce the inaugural International Summit on Psychedelic Therapies for Mental Illness and 2-day Introductory Workshop will take place between 17–20 November 2021 online.
A trip to the doctor
The Monthly, 08 August, 2021
A personal experience of how psychedelics are transforming mental health therapies.
Tania de Jong - Mind Medicine, mental illness, psychedelic-assisted psychotherapy
The Fair Food Forager & Friends Show, 08 August, 2021
Mind Medicine Australia co-founder, Tania de Jong AM, talks about mental illness, psychedelic-assisted therapies and the work we do at Mind Medicine Australia.
Australian experts push for psychedelic medicines to treat mental illness
11 Network Australia, 11 August, 2021
Mind Medicine Australia co-founder, Tania de Jong AM, talks about the benefits of psychedelics, such as MDMA and psilocybin as a treatment option for mental health.
Psychedelic-assisted therapy – potentials for mental illness
Medical Forum, 21 July, 2021
If the latest clinical research holds true, Psychedelic-Assisted Therapy (PAT) could revolutionise our understanding and treatment paradigms for mental illness.
‘Hippie’ drugs show promise for treatment
The Australian, 01 July, 2021
Half a century after hippies gave psychedelics a bad name, psychiatrists are pressing to use the currently illegal medicines to treat mental illness.
New Frontiers of Psychedelics
Perspectives Podcast, 30 June, 2021
Tania de Jong AM speaks about transformation through psychedelic experiences and the work Mind Medicine Australia does.
Ecstasy the solution for soldiers with PTSD, experts say
The Standard, 25 June, 2021
MDMA could help to dramatically reduce the number of suicides among veterans. The Victorian Government is being urged to take the first step. Eddie Russell reports.
Interview with Tania de Jong, one of the founding members of Mind Medicine
Echo, 22 June, 2021
This Sunday 27 and Monday 28 June, Mind Medicine present two days of film and conversation around psychedelic medicine – their first ever symposium on the new science of psychedelics.
Mind Medicine Australia's Canberra chapter calls for access to psychedelics
Canberra Times, 20 June, 2021
Mind Medicine Australia has called on the ACT Government to change “conservative” legislation to improve access to psychedelic-assisted therapy.
Australians still wait for access to psychedelics-assisted therapies
Financial Review, 28 May, 2021
Psychedelics are increasingly finding favour with mental health professionals around the world who are treating patients with intractable conditions such as PTSD, which has a remission rate of just 5 percent using currently available therapies.
Mind Medicine - Saving Veterans' lives
The Project, Channel 10, 27 May, 2021
For years we’ve heard about the epidemic of post-traumatic stress among Aussie veterans. But now there’s a push to use psychedelic drugs to help them get back to health.
The clip starts at: 36:09
Why the TGA should reschedule MDMA and psilocybin for the treatment of mental illness
The Conversation, 20 May, 2021
The down-scheduling of psilocybin and MDMA could have enormous medical benefit for Australian patients, especially when Australia spent A$10.6 billion on mental health between 2018-2019.
Study shows ecstasy plus therapy can treat severe PTSD
AFR, 11 May, 2021
The campaign in Australia to use the drug MDMA together with psychotherapy to treat post-traumatic stress disorder has been strengthened by a study just published in the prestigious journal Nature Medicine.
Read the full article here.
It’s time to give our military the medicine they need
Spectator | Australia, 06 May, 2021
Sadly, many of the more than 39,000 soldiers who served in Afghanistan will have varying degrees of post-traumatic stress disorder (PTSD). Innovative treatments are urgently needed to treat PTSD. With mounting pressure, the TGA recently announced an Independent Review on rescheduling both psylocibin and MDMA.
100 Most Influential People in Psychedelics
Psyched Studio, 05 May, 2021
Mind Medicine Australia’s co-Founder, Tania de Jong AM has been shortlisted in the 100 Most Influential People in Psychedelics by Psyched Studio.
100 Most Influential People in Psychedelics
Psychedelic Invest, 03 May, 2021
Psychedelic Invest has compiled a list of the top 100 most influential people in the psychedelics ecosystem, including our Co-Founder Tania de Jong AM.
Psychedelics for Mental Health
Metagenics Institute Podcast, 27 April, 2021
In this episode, Nathan sits down with Tania de Jong and Dr Alana Roy from Mind Medicine Australia to discuss the use of psychedelics for mental health.
'Illicit drugs' and mental health treatment: all we are asking for is hope
The Canberra Times, 22 April, 2021
“I am writing this as a mother, in the hope that my words may open the closed minds of our politicians and the authorities we rely upon to ensure every Australian has access to the latest medical therapies.” – Annie Mason
The Weekly With Charlie Pickering
The Weekly With Charlie Pickering, 21 April, 2021
Feature on psychedelics in Australia, Mind Medicine Australia and the TGA.
Interview starts at 17:08.
MDMA and magic mushrooms reconsidered for rescheduling by Therapeutic Goods Administration
Canberra Times, 18 April, 2021
An application to make MDMA and psilocybin more easily accessible to psychiatrists for mental health treatments will now be independently reviewed following an earlier rejection.
MDMA and magic mushrooms reconsidered for rescheduling by Therapeutic Goods Administration
Canberra Times, 18 April, 2021
An application to make MDMA and psilocybin more easily accessible to psychiatrists for mental health treatments will now be independently reviewed following an earlier rejection.
It's about patient choice says Tasmanian doctor who believes magic mushrooms and MDMA can help treat depression and PTSD
The Advocate, 25 March, 2021
A Tasmanian doctor says the state’s mental health crisis would be greatly assisted by MDMA and psilocybin assisted therapies, especially for emergency responders impacted by trauma and those with treatment-resistant illness.
It's about patient choice says Tasmanian doctor who believes magic mushrooms and MDMA can help treat depression and PTSD
The Advocate, 25 March, 2021
A Tasmanian doctor says the state’s mental health crisis would be greatly assisted by MDMA and psilocybin assisted therapies, especially for emergency responders impacted by trauma and those with treatment-resistant illness.
Australian government backs psychedelic drug clinical trials to treat mental illness
The Guardian, 18 March, 2021
$15m grant comes despite TGA’s failure to reschedule MDMA and psilocybin from a prohibited substance to a controlled medicine
The Admiral and the Ecstasy
ABC Conversations, 18 March, 2021
Chris Barrie is convinced that the Australian Government should legalise the clinical use of specific psychedelics to help veterans recovering from trauma.
Government commits $15m for psychedelic drug therapy trials
ABC PM with Linda Mottram, 18 March, 2021
The federal government has committed $15 million for the development of psychedelic drug therapies for mental illness. In clinical trials around the world, MDMA, magic mushrooms and ketamine are showing promising results in treating PTSD and depression. Advocacy groups have welcomed the trials but want the prohibited drugs reclassified so they can be used more readily for psycho-therapy.
Psychedelic therapy: Air force veteran’s wild journey back from the abyss
news.com.au, 18 March, 2021
After 16-and-a-half years in the air force, Michael Raymond had seen it all. But by repressing his feelings, he began to push himself down a dark path. His mental health began to deteriorate even further and he was placed on suicide watch. Ultimately, Michael was healed through psychedelic-assisted therapy.
‘Better treatments’: Government to fund psychedelic drugs trials to treat mental illness
The Sydney Morning Herald, 17 March, 2021
Clinical trials using psilocybin, MDMA and other psychedelic medicines in potential breakthrough therapies for debilitating mental illnesses will be funded by the federal government as part of global efforts to advance innovative treatments.
Former trade minister Andrew Robb supports psychedelic medicines
9News, 17 March, 2021
The use of psilocybin, MDMA and other psychedelic medicines to treat mental illness will soon undergo clinical trials funded by the federal government. It’s backed by former Trade Minister Andrew Robb but not all psychiatrists are convinced.
Australian Government to Spend $15m on Psychedelic Trials
VICE, 17 March, 2021
The Australian government will fund a series of clinical trials into the potential use of psilocybin, MDMA, ketamine and other drugs as treatments for debilitating mental illnesses. The $15 million Innovative Therapies for Mental Illness Grant Opportunity aims to bolster Australian-led research into drug and psychedelic-assisted psychotherapy.
Australian War Memorial expansion better invested in psychedelic-assisted therapy research
The Canberra Times, 14 March, 2021
ACT pill testing advocate David Caldicott has voiced disgust over the $500 million expansion of the Australian War Memorial he said the federal government had “inflicted” on the city, while emerging treatments for post traumatic stress disorder were deemed too hard.
Report with Leigh Sales interviewing Andrew Robb AO, Dr Stuart Saker and more
ABC 7.30, 11 March, 2021
Leigh Sales interviewing Andrew Robb AO, psychiatrist Dr Stuart Saker and patient on psychedelic-assisted therapies to treat mental illness. The segment commences at 21:45
Andrew Robb interviewed by James Valentine, ABC Radio Sydney
Afternoons, 11 March, 2021
The interview commences at 1 hour and 2 minutes.
When pills stopped working, Andrew Robb looked to magic mushroom therapy
ABC News, 11 March, 2021
When his daily pile of antidepressant pills stopped working, former Liberal Party director and trade minister Andrew Robb began researching psychedelic therapy as an option to send his depression into remission.